DD

Damini Devlalikar

Active Director Director DIN 09134383
DIN 09134383 First appointment Apr 2021 Primary industry Manufacturing
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value •••• Premium profile

About Damini Devlalikar

Data last updated:

Damini Devlalikar is a Director at Sky Vision Pharma Private Limited (since 2021). The company operates in Manufacturing. Sky Vision Pharma Private Limited reported revenue of ₹1.82 Cr (FY 2025).

DIN 09134383
Primary Designation Director
Industry Manufacturing
First Appointment 05 Apr 2021
Oldest Company Age 5 yrs
Largest company Sky Vision Pharma Private Limited · ₹1.82 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sky Vision Pharma Private Limited U24239MP2021PTC071972
Director05 Apr 20212021₹1.82 Cr (FY 2025)Active

Board colleagues of Damini Devlalikar

Directorship timeline

Open interactive timeline →
Sky Vision Pharma Private Limited
Premium access

Shareholding and investment profile for Damini Devlalikar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Damini Devlalikar

Damini Devlalikar currently holds 1 directorship: Sky Vision Pharma Private Limited (Director, since 05 Apr 2021, revenue ₹1.82 Cr (FY 2025)).

Damini Devlalikar was first appointed on 05 Apr 2021 as Director at Sky Vision Pharma Private Limited.

The current boards of Damini Devlalikar's companies include Isha Singh (Sky Vision Pharma Private Limited), Neha Arora (Sky Vision Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available